Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat

The DOI matches its Crossref record; 65 of the 65 references it cites were found in a registry or an index.

Propranolol for the treatment of anxiety disorders: Systematic review and meta-analysis

Open access
Steenen, Serge A, van Wijk, Arjen J, van der Heijden, Geert JMG, van Westrhenen, Roos, de Lange, Jan, de Jongh, Ad · 2016 · Journal of Psychopharmacology

Abstract

The effects of propranolol in the treatment of anxiety disorders have not been systematically evaluated previously. The aim was to conduct a systematic review and meta-analysis of randomised controlled trials, addressing the efficacy of oral propranolol versus placebo or other medication as a treatment for alleviating either state or trait anxiety in patients suffering from anxiety disorders. Eight studies met the inclusion criteria. These studies concerned panic disorder with or without agoraphobia (four studies, total n = 130), specific phobia (two studies, total n = 37), social phobia (one study, n = 16), and posttraumatic stress disorder (PTSD) (one study, n = 19). Three out of four panic disorder trials qualified for pooled analyses. These meta-analyses found no statistically significant differences between the efficacy of propranolol and benzodiazepines regarding the short-term treatment of panic disorder with or without agoraphobia. Also, no evidence was found for effects of propranolol on PTSD symptom severity through inhibition of memory reconsolidation. In conclusion, the quality of evidence for the efficacy of propranolol at present is insufficient to support the routine use of propranolol in the treatment of any of the anxiety disorders.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1177/0269881115612236

Cites

65 of 65 references verified0 citation errors · 0 not checkable

Statistics

Figures

Figure 1. Flow of information through the different phases of the systematic search.
Figure 1. Flow of information through the different phases of the systematic search.CC BY-NC · PubMed Central
Figure 2. Risk of bias summary figure.
Figure 2. Risk of bias summary figure.CC BY-NC · PubMed Central
Figure 3(a). Meta-analysis I. Propranolol versus benzodiazepines in panic disorder with or without agoraphobia (outcome: number of panic attacks after 2 weeks of treatment).
Figure 3(a). Meta-analysis I. Propranolol versus benzodiazepines in panic disorder with or without agoraphobia (outcome: number of panic attacks after 2 weeks of treatment).CC BY-NC · PubMed Central
Figure 3(b). Meta-analysis II. Propranolol versus benzodiazepines in panic disorder with or without agoraphobia (outcome: HAM-A after 2 weeks treatment).
Figure 3(b). Meta-analysis II. Propranolol versus benzodiazepines in panic disorder with or without agoraphobia (outcome: HAM-A after 2 weeks treatment).CC BY-NC · PubMed Central
Figure 3(c). Meta-analysis III. Propranolol versus benzodiazepines in panic disorder with or without agoraphobia (outcome: HAM-A after 2–6 weeks treatment).
Figure 3(c). Meta-analysis III. Propranolol versus benzodiazepines in panic disorder with or without agoraphobia (outcome: HAM-A after 2–6 weeks treatment).CC BY-NC · PubMed Central
Figure 3(d). Meta-analysis IV. Propranolol versus alprazolam in panic disorder with or without agoraphobia (outcome: HAM-A after 6 weeks treatment).
Figure 3(d). Meta-analysis IV. Propranolol versus alprazolam in panic disorder with or without agoraphobia (outcome: HAM-A after 6 weeks treatment).CC BY-NC · PubMed Central
Figure 3(e). Sensitivity analysis. Meta-analysis III with one study with high risk of selective outcome reporting included and excluded (Ravaris et al., 1991).
Figure 3(e). Sensitivity analysis. Meta-analysis III with one study with high risk of selective outcome reporting included and excluded (Ravaris et al., 1991).CC BY-NC · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 65 references

Research works printed but not linked: 5

  1. Becker AL, 1976, S Afr Med J, 50, 627
  2. Elman MJ, 1998, Trans Am Ophthalmol Soc, 96, 283
  3. Mealy K, 1996, Eur J Surg, 162, 11
  4. Meibach RC, 1987, J Clin Psychiatry, 48, 355
  5. Roy-Byrne P, Stein M, Hermann R (2013) Pharmacotherapy for panic disorder.In: Post T (ed.) UpToDate®. Waltham, MA: UpToDate®. Available at: http://www.uptodate.com/contents/pharmacotherapy-for-panic-disorder (accessed 9 July 2015).

Cited by

See all 237

Metadata

Authors
Steenen, S. A., van Wijk, A. J., van der Heijden, G. J., van Westrhenen, R., de Lange, J., & de Jongh, A.
Affiliations
  • Amsterdam UMC Location University of Amsterdam (NL)
  • Department of Social Dentistry and Behavioural Sciences, Academic Centre for Dentistry Amsterdam, University of Amsterdam and VU University, Amsterdam, the Netherlands
  • Department of Psychiatry, Erasmus University Medical Centre, Rotterdam, the Netherlands
  • Department of Oral and Maxillofacial Surgery, Academic Medical Centre, University of Amsterdam, Amsterdam, the Netherlands
Corresponding author
Steenen, Serge A
Venue
Journal of Psychopharmacology
Published
2015-10-20
Volume
30
Issue
2
Pages
128-139
ISSN
  • 0269-8811 (ISSN-L)
  • 1461-7285
OpenAlex
W2266059207
Cited by
237
References
65
Citations by year
2026: 14 · 2025: 29 · 2024: 31 · 2023: 24 · 2022: 28 · 2021: 24 · 2020: 17 · 2019: 20 · 2018: 24 · 2017: 18 · 2016: 7 · 2015: 1
FWCI
2.17
Type
journal article
Language
en
Open access
Licence
  • cc-by-nc
  • journals.sagepub.com/page/policies/text-and-data-mining-license (tdm)
Locations
  • Journal of Psychopharmacology (publishedVersion, cc-by-nc)
  • PubMed Central (publishedVersion, cc-by-nc)
  • PubMed (publishedVersion)
  • UvA-DARE (University of Amsterdam) (publishedVersion, cc-by-nc)
  • EUR Research Repository (Erasmus University Rotterdam) (publishedVersion)
  • VU Research Portal (publishedVersion, other-oa)
  • Data Archiving and Networked Services (DANS) (submittedVersion)
  • EUR Research Repository (Erasmus University Rotterdam) (submittedVersion)
  • RePub (Erasmus University Rotterdam) (submittedVersion, other-oa)
  • UvA-DARE (University of Amsterdam) (submittedVersion, cc-by-nc)
  • Pure Amsterdam UMC (submittedVersion, other-oa)
  • Data Archiving and Networked Services (DANS) (submittedVersion, other-oa)
Funders
Universiteit van Amsterdam
Topics
  • Social Sciences › Psychology › Experimental and Cognitive Psychology › Anxiety, Depression, Psychometrics, Treatment, Cognitive Processes
  • Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiac Health and Mental Health
  • Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Maternal Mental Health During Pregnancy and Postpartum
Keywords
propranolol, anxiety disorders, panic disorder, agoraphobia, specific phobia, social anxiety disorder, post-traumatic stress disorder, benzodiazepines, memory reconsolidation, state anxiety, trait anxiety, beta-blockers
MeSH terms
Administration, Oral, Adrenergic beta-Antagonists, Anxiety Disorders, Humans, Propranolol, Severity of Illness Index, Anti-Anxiety Agents, Randomized Controlled Trials as Topic

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Propranolol for the treatment of anxiety disorders: Systematic review and meta-analysis. https://app.cochat.ai/papers/10.1177/0269881115612236
The paper
Steenen, S. A., van Wijk, A. J., van der Heijden, G. J., van Westrhenen, R., de Lange, J., & de Jongh, A. (2016). Propranolol for the treatment of anxiety disorders: Systematic review and meta-analysis. Journal of Psychopharmacology. https://doi.org/10.1177/0269881115612236

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.